Black Seed Oil (Nigella sativa): What the Thymoquinone Trials Show

Nigella sativa, known commercially as black seed or black cumin, has been used in Middle Eastern and South Asian medicine for centuries and has become one of the most-studied medicinal plants in the modern peer-reviewed literature. Its principal bioactive thymoquinone (about 0.5 to 1.6 percent of the seed oil) is the basis of most of the trial work, although other components — nigellone, thymohydroquinone, alpha-hederin — likely contribute.

Blood pressure: a reproducible signal

A 2016 meta-analysis by Sahebkar and colleagues of 11 RCTs in 860 adults reported that 8 to 12 weeks of black seed (typically 2 to 3 g of seed or 0.5 to 1 g of oil daily) reduced systolic blood pressure by 3.26 mmHg and diastolic by 2.80 mmHg compared with placebo [1]. The effect is modest but consistent and approaches what would be expected from a single low-dose antihypertensive. Mechanistic studies suggest thymoquinone enhances endothelial nitric oxide and modestly inhibits angiotensin-converting enzyme.

Lipids: stronger LDL effects than expected

A 2017 meta-analysis of 17 RCTs reported reductions in total cholesterol of 9.4 mg/dL, LDL of 10.1 mg/dL, and triglycerides of 16.3 mg/dL with N. sativa supplementation, with HDL roughly unchanged [2]. The effect size on LDL is comparable to a low dose of plant stanols and slightly larger than soluble fiber alone, although meaningfully less than even low-dose statin therapy. Trials with longer duration and oil rather than seed reported larger effects.

Type 2 diabetes adjunct

Several Egyptian and Iranian trials have tested 1 to 2 g of seed daily in patients already on metformin, reporting HbA1c reductions of 0.5 to 1.0 percentage points over 12 weeks [3]. A 2022 umbrella review pooled these and confirmed modest but consistent fasting glucose and HbA1c reductions, with a caution about the dominance of small-to-medium trials from a small number of regions [4]. As an adjunct to metformin, the effect size is meaningful; as monotherapy for diabetes it has not been adequately tested.

Allergic rhinitis and asthma

An older Egyptian trial randomized 66 patients with allergic rhinitis to 0.5 mL of N. sativa oil intranasally or placebo for six weeks and reported substantial reduction in nasal congestion, itching, and sneezing [5]. Asthma trials with 1 to 2 g per day of seed for 12 weeks have shown improved symptom scores and FEV1 in adults on standard inhaler therapy [6]. The mechanism likely involves inhibition of mast cell histamine release and IL-4 suppression.

Safety profile

Black seed is generally well tolerated. Reported adverse effects are limited to mild gastrointestinal symptoms and occasional contact dermatitis with topical use. Hypotension and hypoglycemia are theoretically additive with antihypertensive and antidiabetic medications, so adults on multiple antihypertensives, sulfonylureas, or insulin should monitor closely when adding it. Animal data suggest possible cytochrome P450 interactions; data on warfarin interaction are limited but caution is warranted. Pregnancy data are insufficient and the seed has historically been used as a uterotonic, so it should be avoided during pregnancy.

Practical dosing

Trial doses cluster at 1 to 2 g of ground seed twice daily, or 0.5 to 1.0 g of cold-pressed oil daily. Thymoquinone content varies by manufacturer; products standardized to 0.5 to 1 percent thymoquinone are more likely to match trial chemistry. Refrigeration prolongs oil stability; rancid oil loses thymoquinone and bioactivity.